David Bredt

Insider Reports History

Location
Boston, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Bredt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Scientific Officer Common Stock 395,575 $10,838,755 $27.40 15 Jan 2026 Direct
Rapport Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 100,000 03 Feb 2025 Direct

Insider Reports Filed by David Bredt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 15 Jan 2026 2 -$228,132 4 Chief Scientific Officer 16 Jan 2026, 16:06
RAPP Rapport Therapeutics, Inc. 31 Dec 2025 2 -$197,338 4 Chief Scientific Officer 05 Jan 2026, 16:20
RAPP Rapport Therapeutics, Inc. 15 Dec 2025 2 -$255,130 4 Chief Scientific Officer 16 Dec 2025, 17:07
RAPP Rapport Therapeutics, Inc. 17 Nov 2025 2 -$214,091 4 Chief Scientific Officer 18 Nov 2025, 16:24
RAPP Rapport Therapeutics, Inc. 15 Oct 2025 2 -$219,196 4 Chief Scientific Officer 16 Oct 2025, 16:30
RAPP Rapport Therapeutics, Inc. 15 Sep 2025 2 -$205,649 4 Chief Scientific Officer 17 Sep 2025, 16:15
RAPP Rapport Therapeutics, Inc. 15 Aug 2025 2 -$127,466 4 Chief Scientific Officer 18 Aug 2025, 17:14
RAPP Rapport Therapeutics, Inc. 15 Jul 2025 1 -$118,962 4 Chief Scientific Officer 16 Jul 2025, 16:14
RAPP Rapport Therapeutics, Inc. 16 Jun 2025 1 -$93,522 4 Chief Scientific Officer 18 Jun 2025, 16:15
RAPP Rapport Therapeutics, Inc. 15 May 2025 1 -$81,262 4 Chief Scientific Officer 19 May 2025, 16:30
RAPP Rapport Therapeutics, Inc. 15 Apr 2025 1 -$81,310 4 Chief Scientific Officer 16 Apr 2025, 17:00
RAPP Rapport Therapeutics, Inc. 14 Mar 2025 1 -$92,205 4 Chief Scientific Officer 17 Mar 2025, 17:00
RAPP Rapport Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Scientific Officer 04 Feb 2025, 17:30
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 1 $0 4 Chief Scientific Officer 10 Jun 2024, 19:43
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Chief Scientific Officer 06 Jun 2024, 19:03